Intrinsic Respiratory Rate Test During Mechanical Ventilation to Help Spontaneous Breathing and Extubation
Official title: Assessing Intrinsic Respiratory Rate in Mechanically Ventilated Adult Patients With Reverse Triggering as an Incentive for Accelerating Transition to Spontaneous Breathing and Extubation: Pilot Randomized Clinical Trial - INTRINSIC
Run by Unity Health Toronto · NCT06445049 · Data updated 2026-11-12
This pilot randomized trial tests a brief intrinsic breathing rate check during ventilation to see if it helps patients with reverse triggering breathe on their own and be extubated sooner.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 70 (estimated) |
| Sponsor | Unity Health Toronto Academic / other |
| Locations | 2 sites (Toronto, Ontario and 1 other locations) |
| Status | Recruiting |
| Started | August 25, 2025 |
| Main results expected | June 30, 2027 |
| Study ends | June 30, 2027 |
| Registry record updated | November 10, 2026 |
| Trial ID | NCT06445049 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adult patients on controlled ventilation with reverse triggering, at two Toronto ICUs.
✕Probably not a fit
Patients without reverse triggering or those not meeting intrinsic rate criteria may not benefit from the intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The study enrolls 70 adults with reverse triggering who are on controlled ventilation in two Toronto ICUs. After screening, participants are randomized to standard care or a brief intervention that includes a short intrinsic respiratory rate assessment and a possible 5-minute pressure-support test if criteria are met. The goal is to see whether identifying intrinsic rate improves transition to spontaneous breathing and successful extubation. Safety excludes those on continuous neuromuscular blockade or with severe metabolic acidosis. The trial uses a deferred consent model and is led by Unity Health Toronto with sites at St. Michael's and Toronto Western Hospitals.
Why it matters
Potential benefit: If successful, the approach could help clinicians identify patients who can breathe spontaneously sooner and may reduce time on the ventilator.
How similar studies have gone: Previous work has explored ventilator strategies to promote spontaneous breathing, but this exact intrinsic-rate assessment approach is novel in this setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients (aimed at equal number of men and woman) sedated and under controlled ventilation having reverse triggering. Exclusion Criteria: * under current use of continuous neuromuscular blocking agent or severe metabolic acidosis (Ph\<7.25) at the time of study procedure.
Where it's running
-
St. Michael's Hospital
Toronto, Ontario, Canada Recruiting -
Toronto Western Hospital
Toronto, Ontario, Canada Not yet recruiting
Study contacts
- Principal investigator: Laurent Brochard — Unity Health Toronto - St. Michael's Hospital
- Study coordinator: Laurent Brochard, MD
- Email: laurent.brochard@unityhealth.to
- Phone: 4168645686
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Friends and family training for those at risk of suicide
A six-week program tests whether training for caregivers can help them support a loved one at risk of suicide while also taking care of their own mental health.
-
Supporting social and economic equity to help young people move out of homelessness and thrive
This pilot will try an 18-month wraparound program of job help, housing supports, grocery supplements, coaching and community connection for 18–24-year-olds who recently experienced homelessness to see if they engage and find it helpful.
-
Digital app to support oncologist‑initiated genetic testing
This project tests a digital app (GA‑Mainstream) to help oncologists offer germline genetic testing to adults with breast, prostate, colon, or other GI cancers.
-
TreatResp: adaptive study of breathing infections therapies for community care
This trial tests baloxavir vs. standard care in adults with influenza or similar respiratory infections to see if new treatments help people recover faster when kept at home.
-
MDMA for severe chronic neuropathic pain
This will try a single oral dose of MDMA combined with psychotherapy to see if it reduces pain and improves function in adults with moderate-to-severe chronic neuropathic pain that hasn't responded to standard medications.
-
AbClo abdominal binder's effects on breathing mechanics in ventilated patients with an open abdomen
This test will see if adjusting the AbClo abdominal binder changes lung pressures, lung volume, and breathing function in adults on ventilators with an open abdomen.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.